Q4 2024 Earnings Call Transcript November 12, 2024 Operator: Greetings and welcome to the Azenta Fourth Quarter 2024 ...
Moving on to the business, I'm pleased to share Azenta delivered strong results in the quarter and in the year despite a depressed and uncertain life sciences market ... our daily operating decisions ...
There is an opportunity for GenAI to help bring better and safer drugs to market faster and more cost-efficiently, ...
a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights ...
ACROMETA intends to divest its life-sciences business as part of a review of its long-term strategy, the specialist engineering firm said on Monday (Oct 21). The group has entered into an agreement to ...
The prime minister said it would mean the government “not just stepping back but stepping up to a new, active role that backs business ... for any UK life sciences industrial strategy will ...
Life science labs exist to push the boundaries of science and technology for the benefit of humanity. But federal laws and new environmental, health and safety (EHS) regulations are keeping step ...
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Investor ... the opportunity to ...
Stakeholder engagement in the pharmaceutical and life sciences sectors has evolved ... relations and communications to drive business strategy and internal change. The views expressed are the ...
McNamara's extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies brings a wealth of expertise to accelerate Yunu's life sciences business.
Q3 2024 Earnings Call Transcript November 2, 2024 Operator: Good morning, ladies and gentlemen, and welcome to Anika’s Third Quarter Earnings Conference Call. [Operator Instructions]. I would like to ...